The Neuro Skip to main content Make your mark Explore by Big Idea Opportunities that open doors Research that changes lives Innovation that drives progress Shaping future-ready students Causes That Matter The McGill Sustainability Park Building a healthier McGill Collaborating for responsible AI Supporting Indigenous excellence Faculties, Schools and Units Agricultural & Environmental Sciences Arts Continuing Studies Dental Medicine and Oral Health Sciences Education Engineering Law McGill Libraries Desautels Faculty of Management Medicine and Health Sciences Schulich School of Music Science Athletics & Recreation The Neuro Faculties, Schools and Units Ways to give Ways to give Make your mark by supporting students, giving to your faculty or funding an innovative project. Give today Online By phone By mail Wire transfers Securities McGill staff payroll deductions Gift matching options Give tomorrow Leave a bequest Life insurance Retirement plan assets Charitable remainder trusts More ways to give International giving Corporations Foundations Endowed giving McGill Crowdfunding McGill24 Get involved Get involved Be part of McGill's global community. Read our award-winning magazine, The McGill News, attend exciting events featuring top researchers, take advantage of networking and mentorship opportunities and more. [] Attend an event Global Tour Volunteer McGill Fund Leadership Council Planned Giving Ambassadors Strategic Giving Council McGill stories Submit your McGill stories About About Discover Make your mark [] President's message Advancement Council The McGill Fund Legacy Societies Français Search Search fr Give Home Make your mark Faculties, Schools and Units The Neuro The Neuro Revolutionizing neuroscience. Transforming lives. Make a gift Choose an amount $50 $250 $500 $1000 Or enter your amount CAD USD Give Explore {{ element.dataset.anchor }} More than 100 million people around the world suffer from a disease or disorder of the brain – and the number is increasing. To meet this global challenge, we not only have to do more and do better; we need to radically transform our approach to brain science. Led by the Montreal Neurological Institute-Hospital (The Neuro), McGill is revolutionizing brain research in order to accelerate the discovery of new treatments and cures. Our strategy: Open Science. As the first and still the only Open Science institution in the world, The Neuro is developing the tools and the infrastructure needed to support data and material sharing with the research community worldwide. Bringing together expertise from across health and basic science disciplines. Working hand-in-hand with patients and their families. Sharing our research with a global community, and encouraging scientists worldwide to embrace this new way of doing research. Expanding the impact of our research – and growing scientific knowledge to deliver new treatments. Our bold strategy has the promise to change how the world’s researchers advance neuroscience, and better capitalize on innovations in biomedical science and big data technology. Driven by a pioneering vision and fueled by philanthropy, together we have the power to change millions of lives. Discover our vision for the future Accelerating discovery to treat patients with neurological disease With patients at the centre of our motivation, and driven by Open Science principles and transformative technology, we aim to accelerate innovation, discovery and improve care in four critical disease areas: Neurodegenerative diseases: Parkinson’s disease, ALS and other movement disorders are among the most prevalent and fastest-growing neurodegenerative conditions. Neurodevelopmental disorders: Neurodevelopmental disorders include autism spectrum disorder (ASD), intellectual or learning disabilities, attention-deficit/hyperactivity disorder (ADHD), epilepsy, cerebral palsy and schizophrenia. They affect more children than any other childhood disability: an estimated one in six in the world. Brain tumours: Brain tumours affect people of all ages. They are the leading cause of solid cancer death in children under the age of 20, and the third leading cause of solid cancer death in young adults, ages 20 to 39. Rare neurological diseases: As patients and family members deal with the overwhelming challenges of rare neurological diseases like spastic paraplegia, ARSACS, and ataxias, they face a dual burden: the disease itself, and the knowledge that most research funding and drug discovery efforts focus on more common ailments. Leading the way to a new era of science through Open Science In 2016, The Neuro became the first research institute in the world to adopt Open Science as an operating principle. This no-barrier approach to scientific research is gaining ground within the academic community. Read more ... It promises to accelerate research, improve the quality of results, and reinvent discovery itself. We want to accelerate the discovery of novel therapeutics to treat patients suffering from neurological disease through our Open Science initiatives and the latest in brain imaging technology: An Open Neurological Diseases Repository: A game-changing, open biobank collection that we will share with our research partners in order to feed the discovery of biomarkers to improve diagnosis, accelerate drug development and open up new areas of research. A unique Open Early-Drug-Discovery Unit: Our unique early-drug-discovery unit removes proprietary barriers that prevent institutions from sharing early-stage data, allowing research partners to identify and test drug targets collaboratively, and collaborate with pharmaceuticals to develop new drugs. This will result in new drugs moving more quickly to clinical trials, and ultimately, in better therapies for patients. A robust Open Data-Analytics and Data-Sharing Platform: Scientists at The Neuro have been pioneering neuroinformatics platforms since the early 1990s. We will integrate, analyze and share neuroscience data safely and usably with our researcher partners via sophisticated software and a special infrastructure developed by our neuroinformatics experts. A world-leading Open Multi-modal Brain Imaging Centre: For more than 30 years, our McConnell Brain Imaging Centre has led the world in state-of-the-art imaging technologies. In 2019, we took the next step, creating a Centre for Ultra-High-Field Brain Imaging, which includes Canada’s first whole body 7T MRI scanner. By further enhancing our imaging capability and integrating it into our multi-disciplinary research, we will better understand the development of the mechanisms of disease, give more precise diagnostics, and advance the testing of potential drugs. Explore by story {{ article.description }} See all news and stories Make a gift Choose an amount $50 $250 $500 $1000 Or enter your amount CAD USD Give Thanks for your subscription, we’ll keep you posted! Stay in the know Get regular updates: news on our latest discoveries, interviews with our experts and inspirational stories about our students delivered to your inbox. {{ notification.message }} Subscribe again Try again Subscribe Contact Contact Us 514.398.5000 1.800.567.5175 University Advancement 1430 Peel Street Montreal, QC, H3A 3T3 Get Directions Giving to McGill Make your mark Ways To Give About Explore Opportunities Research Innovation Future-ready Faculties, Schools and Units More from McGill Facebook Instagram Twitter YouTube LinkedIn McGill Alumni Get involved Copyright © McGill University. All rights reserved Policy on responsible use Privacy notice